Future Retirement Success
  • Politics
  • Business
  • Investing
  • Stocks
  • Politics
  • Business
  • Investing
  • Stocks

Future Retirement Success

Business

Lancaster University spinout wins major backing to revolutionise healthcare diagnostics

by February 6, 2025
February 6, 2025
Lancaster University spinout wins major backing to revolutionise healthcare diagnostics

Lancaster-based startup CCI Photonics has secured significant new funding to develop its groundbreaking technology for rapid infection detection and antibiotic screening.

Launched by Lancaster University researchers, the spinout aims to deliver test results in as little as 15 minutes—dramatically faster than traditional methods, which can take up to 72 hours.

The investment pot includes £200,000 from the Northern Powerhouse Investment Fund II (NPIF II) PraeSeed programme, £150,000 from the Infection Innovation Consortium (iiCON), and £100,000 from Lyva Labs via Liverpool City Region Combined Authority. CCI Photonics has also received backing from ICURe Innovate UK and holds additional support through a UKRI Novel Technologies Grant.

At the heart of this innovation is InfectiScan, a powerful in vitro diagnostic device that uses infrared spectrometry and advanced AI models to pinpoint bacterial infections in bodily fluids—and determine the most effective antibiotics to prescribe. Founded on research undertaken in partnership with the University Hospitals of Morecambe Bay NHS Foundation Trust (UHMBT), the technology is designed to tackle antibiotic resistance by reducing the guesswork in prescribing antibiotics.

Current diagnostic tools often leave clinicians prescribing treatments on a “best guess” basis, contributing to the rise of antibiotic resistance and increasing the likelihood of ineffective care or infection recurrence. With CCI Photonics’ InfectiScan device, healthcare professionals will be able to rapidly identify pathogens and confirm antibiotic suitability, significantly improving patient outcomes.

Dr Meza Ramirez, Chief Executive of CCI Photonics, emphasised: “This funding allows us to take critical steps in validating and refining our technology. With the support of our partners, we are working to bring a practical solution to healthcare challenges.”

Professor Craig Williams, Consultant Microbiologist at UHMBT, echoed this sentiment: “I hope this ongoing research will provide much more rapid diagnosis, leading to better infection treatment outcomes at a time when bacteria are becoming more resistant to commonly used antibiotics.”

Professor Janet Hemingway, founding director of iiCON, also underlined the importance of disruptive technologies in the fight against infectious diseases, noting the urgent global health challenge and the need for swift innovation.

By combining world-class research, strong funding, and practical clinical collaboration, CCI Photonics is poised to transform infectious disease diagnostics—potentially slashing test turnaround times from days to minutes and helping to stave off the looming threat of antibiotic resistance.

Read more:
Lancaster University spinout wins major backing to revolutionise healthcare diagnostics

0
FacebookTwitterGoogle +Pinterest
previous post
BT scraps diversity targets from managers’ bonuses
next post
Re N Tox: Medical Spa RX Delivers a Breakthrough in Wrinkle Treatment

You may also like

Sky Zero Footprint Fund returns in 2025 with...

March 1, 2025

How to Care for Real Sheepskin Rugs

March 6, 2023

Train strikes ‘could cost hospitality sector over £1.5bn’...

December 23, 2022

Paris hotels see surge in revenue as Olympic...

August 1, 2024

Bookings Open for The Royal Ballet School’s 2025...

January 22, 2025

Train drivers announce new week-long overtime ban

July 25, 2023

Key considerations for succession planning for business owners

September 2, 2022

Royal Mail Faces Legal Battle Over Gig Economy...

February 26, 2024

The Wealthy Wayfarer: Personal Finance Tips for the...

April 21, 2024

Make UK backs Labour’s industrial strategy, sees surge...

October 21, 2024

    Get free access to all of the retirement secrets and income strategies from our experts! or Join The Exclusive Subscription Today And Get the Premium Articles Acess for Free

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • Rescissions: A Small but Welcome Step Toward Spending Discipline

      June 5, 2025
    • DAVID MARCUS: Why Navy ships should not be named for gay rights icons

      June 5, 2025
    • GREGG JARRETT: Biden, the ‘marionette president; and the case of the runaway autopen

      June 5, 2025
    • Trump Practically Bans Travel and Immigration from 12 Countries with Flimsy Security Justifications

      June 5, 2025
    • ‘He’s not a big factor’: Trump’s Senate allies dismiss Elon Musk’s calls to ‘kill the bill’

      June 5, 2025
    • Fears grow that Tata Steel could be excluded from Starmer-Trump trade deal

      June 5, 2025

    Categories

    • Business (8,147)
    • Investing (2,008)
    • Politics (15,523)
    • Stocks (3,127)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: futureretirementsuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 futureretirementsuccess.com | All Rights Reserved